Business & MarketsBusiness Columnists

Negotiating Prescription Drug Prices Won’t Resolve the Real Problems of Health Costs

Save
Negotiating Prescription Drug Prices Won’t Resolve the Real Problems of Health Costs
The tools for good diabetes management.
J.G. Collins
Updated:
0:00
Commentary

The Biden administration and the Democratic National Committee took a premature victory lap last week for their purported “victory” to negotiate prescription prices. The fawning corporate media dutifully carried their water, reading off the Democratic National Committee talking points as if they were “news,” in an embarrassing display of how sadly the Fourth Estate in this country has declined.

J.G. Collins
J.G. Collins
Author
J.G. Collins is managing director of the Stuyvesant Square Consultancy, a strategic advisory, market survey, and consulting firm in New York. His writings on economics, trade, politics, and public policy have appeared in Forbes, the New York Post, Crain’s New York Business, The Hill, The American Conservative, and other publications.
Related Topics